Publicaciones en colaboración con investigadores/as de Hospital de la Santa Creu i Sant Pau (18)

2024

  1. Metabolic dysfunction-associated steatohepatitis (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) require urgent attention by primary care physicians and endocrinologists

    Endocrinologia, Diabetes y Nutricion, Vol. 71, Núm. 4, pp. 149-151

  2. The role of basal insulins in the treatment of people with type 2 diabetes and chronic kidney disease: A narrative review

    Diabetes, Obesity and Metabolism, Vol. 26, Núm. 4, pp. 1157-1170

2023

  1. Is the Spanish type 1 diabetes mellitus registry really necessary?

    Endocrinologia, Diabetes y Nutricion, Vol. 70, Núm. 10, pp. 617-618

2022

  1. Executive summary of the consensus statement of: Clinical recommendations for sport practice in people with diabetes (RECORD Guide). Update 2021. Diabetes Mellitus Area of the Spanish Society of Endocrinology and Nutrition (SEEN)

    Endocrinologia, Diabetes y Nutricion, Vol. 69, Núm. 9, pp. 732-743

  2. Impact of COVID-19 Lockdown in Eating Disorders: A Multicentre Collaborative International Study

    Nutrients, Vol. 14, Núm. 1

  3. Initial clinical and treatment patterns of advanced differentiated thyroid cancer: ERUDIT study

    European Thyroid Journal, Vol. 11, Núm. 5

  4. Registro del Grupo NADYA-SENPE de Nutrición Enteral Domiciliaria en España: años 2018 y 2019

    Nutricion hospitalaria, Vol. 39, Núm. 1, pp. 223-229

2021

  1. COULD THE COVID-19 PANDEMIC BE AN OPPORTUNITY FOR IMPROVEMENT OF OUR CARE, TRAINING AND RESEARCH ACTIVITIES?

    Endocrinologia, Diabetes y Nutricion, Vol. 68, Núm. 2, pp. 79-81

2019

  1. Treatment of Type 2 Diabetes by Patient Profile in the Clinical Practice of Endocrinology in Spain: Delphi Study Results from the Think Twice Program

    Diabetes Therapy, Vol. 10, Núm. 5, pp. 1893-1907

2017

  1. Consensus on the management of advanced radioactive iodine-refractory differentiated thyroid cancer on behalf of the Spanish Society of Endocrinology Thyroid Cancer Working Group (GTSEEN) and Spanish Rare Cancer Working Group (GETHI)

    Clinical and Translational Oncology, Vol. 19, Núm. 3, pp. 279-287

  2. FGF19 and FGF21 serum concentrations in human obesity and type 2 diabetes behave differently after diet- or surgically-induced weight loss

    Clinical Nutrition, Vol. 36, Núm. 3, pp. 861-868

  3. Spanish consensus for the management of patients with anaplastic cell thyroid carcinoma

    Clinical and Translational Oncology, Vol. 19, Núm. 1, pp. 12-20

2016

  1. Consensus on management of advanced medullary thyroid carcinoma on behalf of the Working Group of Thyroid Cancer of the Spanish Society of Endocrinology (SEEN) and the Spanish Task Force Group for Orphan and Infrequent Tumors (GETHI)

    Clinical and Translational Oncology, Vol. 18, Núm. 8, pp. 769-775

  2. El Registro Molecular de Adenomas Hipofisarios (REMAH): una apuesta de futuro de la Endocrinología española por la medicina individualizada y la investigación traslacional

    Endocrinología y nutrición: órgano de la Sociedad Española de Endocrinología y Nutrición, Vol. 63, Núm. 6, pp. 274-284

2015

  1. Opposite alterations in FGF21 and FGF19 levels and disturbed expression of the receptor machinery for endocrine FGFs in obese patients

    International Journal of Obesity, Vol. 39, Núm. 1, pp. 121-129

2013

  1. A role for adipocyte-derived lipopolysaccharide-binding protein in inflammation- and obesity-associated adipose tissue dysfunction

    Diabetologia, Vol. 56, Núm. 11, pp. 2524-2537

  2. Insuficiencia suprarrenal y su tratamiento sustitutivo. Su realidad en España

    Endocrinologia y Nutricion

2009

  1. Guía clínica para el diagnóstico y el tratamiento de la disfunción tiroidea subclínica en la gestación

    Endocrinologia y Nutricion, Vol. 56, Núm. 2, pp. 85-91